Founded in 2010 by a longtime aortic-valve researcher, Thubrikar Aortic Valve develops transcatheter aortic valve systems for treating aortic stenosis. Its investigational Optimum TAVI System is based on more than 30 years of research into the geometry and mechanics of the natural valve, with durability as a central design goal. The privately held, clinical-stage company has partnered with Brazil’s Labcor Laboratórios and is conducting studies in Europe.